MedTrace Logo

3D Echocardiography and Cardiovascular Prognosis in Mitral Regurgitation

NCT04442828 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-09-25

No results posted yet for this study

Summary

The 3D-PRIME study will analyse whether use of 3D echocardiography can improve risk stratification and cardiovascular outcome in patients with mitral regurgitation of different etiologies.

Conditions

  • Mitral Regurgitation

Interventions

DIAGNOSTIC_TEST

Use of 3D echocardiography in patient follow-up

Patients will undergo clinical and echocardiographic examination including detailed 3D echocardiography at study inclusion and at least one follow-up visit.

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-17
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04442828 on ClinicalTrials.gov